Hint mode is switched on Switch off

XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Choose all Reset all
 
(%)
US78464A8707
XBI ISIN
Exchange Traded Funds (ETF)
Type of fund
SPDR State Street Global Advisors
Provider
129.91 USD
NAV per Share | 03/06/2026
31/01/2006
Inception Date
4 times per year
Dividend payments
CEOILS
CFI
XBI
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
S&P Biotechnology Select Industry Index
Benchmark
0.35 %
Total Cost Ratio
8,054.36 mln USD
Fund NAV | 03/06/2026
8,054.36 mln USD
Share Class NAV | 03/06/2026
No
UCITS
1 / 3 (11/09/2015)
Split

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Yield on 03/06/2026, NYSE Arca

  • YTD
    5.06 %
  • 1M
    -7.93 %
  • 3M
    1.65 %
  • 6M
    11.2 %
  • 1Y
    62.15 %
  • 3Y
    51.47 %
  • 5Y
    0.91 %
  • 10Y
    143.19 %
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (XBI)

Explore the most comprehensive database

1 000 000

bonds

80 234

stocks

167 970

ETF & Funds

70 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

Fund profile

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI profile

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

Structure XBI on 02/06/2026

Download structure in Excel
Paper Value
REVOLUTION MEDICINES INC 1.83%
TWIST BIOSCIENCE CORP 1.8%
ALKERMES PLC 1.79%
TRAVERE THERAPEUTICS INC 1.75%
TG THERAPEUTICS INC 1.57%
ARROWHEAD PHARMACEUTICALS IN 1.47%
NEUROCRINE BIOSCIENCES INC 1.44%
EXELIXIS INC 1.4%
KRYSTAL BIOTECH INC 1.38%
CYTOKINETICS INC 1.34%
BEAM THERAPEUTICS INC 1.34%
VERACYTE INC 1.33%
NATERA INC 1.3%
APOGEE THERAPEUTICS INC 1.27%
MADRIGAL PHARMACEUTICALS INC 1.26%
CRISPR THERAPEUTICS AG 1.25%
PTC THERAPEUTICS INC 1.25%
SCHOLAR ROCK HOLDING CORP 1.25%
MIRUM PHARMACEUTICALS INC 1.21%
HALOZYME THERAPEUTICS INC 1.2%
UNITED THERAPEUTICS CORP 1.19%
BIOGEN INC 1.19%
IONIS PHARMACEUTICALS INC 1.17%
INCYTE CORP 1.17%
PROTAGONIST THERAPEUTICS INC 1.16%
ROIVANT SCIENCES LTD 1.15%
ABBVIE INC 1.14%
RHYTHM PHARMACEUTICALS INC 1.13%
IMMUNOVANT INC 1.13%
NUVALENT INC A 1.1%
COGENT BIOSCIENCES INC 1.09%
BRIDGEBIO PHARMA INC 1.08%
ALNYLAM PHARMACEUTICALS INC 1.07%
BIOMARIN PHARMACEUTICAL INC 1.06%
KYMERA THERAPEUTICS INC 1.05%
IMMUNITYBIO INC 1.05%
GILEAD SCIENCES INC 1.05%
SPYRE THERAPEUTICS INC 1.05%
AMGEN INC 1.05%
PRAXIS PRECISION MEDICINES I 1.05%
VERTEX PHARMACEUTICALS INC 1.04%
SUMMIT THERAPEUTICS INC 1.03%
ARCUTIS BIOTHERAPEUTICS INC 1.02%
ACADIA PHARMACEUTICALS INC 1.01%
CATALYST PHARMACEUTICALS INC 1.01%
CG ONCOLOGY INC 1.01%
VAXCYTE INC 0.99%
VIKING THERAPEUTICS INC 0.99%
MODERNA INC 0.98%
DISC MEDICINE INC 0.98%
ULTRAGENYX PHARMACEUTICAL IN 0.96%
CELCUITY INC 0.95%
REGENERON PHARMACEUTICALS 0.94%
ERASCA INC 0.91%
INSMED INC 0.9%
GRAIL INC 0.89%
RECURSION PHARMACEUTICALS A 0.86%
VERA THERAPEUTICS INC 0.85%
DYNE THERAPEUTICS INC 0.84%
IMMUNOME INC 0.81%
BIOCRYST PHARMACEUTICALS INC 0.79%
DENALI THERAPEUTICS INC 0.78%
ARCUS BIOSCIENCES INC 0.75%
AGIOS PHARMACEUTICALS INC 0.73%
MINERALYS THERAPEUTICS INC 0.73%
SAREPTA THERAPEUTICS INC 0.71%
INTELLIA THERAPEUTICS INC 0.7%
DIANTHUS THERAPEUTICS INC 0.68%
NOVAVAX INC 0.68%
NURIX THERAPEUTICS INC 0.65%
IDEAYA BIOSCIENCES INC 0.64%
UNIQURE NV 0.64%
KODIAK SCIENCES INC 0.63%
RELAY THERAPEUTICS INC 0.63%
SYNDAX PHARMACEUTICALS INC 0.61%
TANGO THERAPEUTICS INC 0.6%
VIRIDIAN THERAPEUTICS INC 0.6%
ARDELYX INC 0.6%
ORUKA THERAPEUTICS INC 0.6%
SELLAS LIFE SCIENCES GROUP I 0.55%
BIOHAVEN LTD 0.55%
VERICEL CORP 0.55%
MANNKIND CORP 0.53%
ADMA BIOLOGICS INC 0.53%
CELLDEX THERAPEUTICS INC 0.5%
MONTE ROSA THERAPEUTICS INC 0.5%
IOVANCE BIOTHERAPEUTICS INC 0.47%
CAREDX INC 0.46%
STOKE THERAPEUTICS INC 0.46%
TAYSHA GENE THERAPIES INC 0.46%
CAPRICOR THERAPEUTICS INC 0.46%
KALVISTA PHARMACEUTICALS INC 0.41%
ABSCI CORP 0.41%
PALVELLA THERAPEUTICS INC 0.41%
INHIBRX BIOSCIENCES INC 0.39%
HYPERLIQUID STRATEGIES 0.38%
OLEMA PHARMACEUTICALS INC 0.38%
ANAPTYSBIO INC 0.37%
CORVUS PHARMACEUTICALS INC 0.35%
PRECIGEN INC 0.33%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.